Delivering a very early nutrition intervention for patients with upper gastrointestinal and lung cancers at home using technology: a pilot randomised trial.

Not Applicable

Completed

• Conditions: pper gastrointestinal cancer; Lung cancer; Upper gastrointestinal cancer; Cancer - Stomach; Cancer - Oesophageal (gullet); Cancer - Lung - Small cell

• Registration Number: ACTRN12616000246482
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. A new histological diagnosis of cancer of the upper gastrointestinal or lung cancer and are to undergo surgery and/or chemotherapy and/or definitive chemoradiotherapy
2. 18 years or over
3. Competency to consent
4. Provision of consent

Exclusion Criteria

Palliative care only is being provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health-Related Quality of Life as measured by the European Organisation for Research and Treatment of Cancer Global Quality of Life questionnaire C30 (EORTC QLQ C30) and EQ-5D.[Four timepoints for the collection of Health-Related Quality of Life. These are baseline = at time of diagnosis; early follow-up = at commencement of surgery; mid follow-up = at commencement of neoadjuvant chemotherapy and at 26 weeks = end of study. ]

Secondary Outcome Measures

Name	Time	Method
utritional status as measured by the Patient-Generated Subjective Global Assessment.[Four timepoints for the collection of nutritional status. These are baseline = at time of diagnosis; early follow-up = at commencement of surgery; mid follow-up = at commencement of neoadjuvant chemotherapy and at 26 weeks = end of study. ]